US HB937 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 31 2019 - 25% progression, died in committee
Action: 2019-01-31 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 31 2019 - 25% progression, died in committee
Action: 2019-01-31 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
Title
Right Rebate Act of 2019
Sponsors
Rep. Kurt Schrader [D-OR] | Sen. Peter Welch [D-VT] |
History
Date | Chamber | Action |
---|---|---|
2019-01-31 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-01-31 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2019-01-31 | House | Referred to the Subcommittee on Health. |
2019-01-31 | House | Introduced in House |
Same As/Similar To
SB205 (Related) 2019-01-24 - Read twice and referred to the Committee on Finance.
HB1839 (Related) 2019-04-18 - Became Public Law No: 116-16. (TXT | PDF)
HB1839 (Related) 2019-04-18 - Became Public Law No: 116-16. (TXT | PDF)
Subjects
Business records
Civil actions and liability
Health
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
Civil actions and liability
Health
Home and outpatient care
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/937/all-info |
Text | https://www.congress.gov/116/bills/hr937/BILLS-116hr937ih.pdf |